92 related articles for article (PubMed ID: 3003560)
21. Epinephrine-induced sequestration of the beta-adrenergic receptor in cultured S49 WT and cyc- lymphoma cells.
Clark RB; Friedman J; Prashad N; Ruoho AE
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):97-119. PubMed ID: 2984267
[TBL] [Abstract][Full Text] [Related]
22. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
Galant SP; Allred SJ
J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
[TBL] [Abstract][Full Text] [Related]
23. Multiple effects of phorbol esters on hormone-sensitive adenylate cyclase activity in S49 lymphoma cells.
Bell JD; Brunton LL
Am J Physiol; 1987 Jun; 252(6 Pt 1):E783-9. PubMed ID: 3035937
[TBL] [Abstract][Full Text] [Related]
24. Bromoacetylalprenololmenthane binding to beta-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells.
Box RJ; Staehelin M
FEBS Lett; 1987 Apr; 214(2):323-6. PubMed ID: 3032686
[TBL] [Abstract][Full Text] [Related]
25. Modulation of catecholamine activation of adenylate cyclase by the number of active beta-adrenergic receptors: theoretical considerations on the role of receptor diffusion in the cell membrane.
Swillens S
J Cyclic Nucleotide Res; 1982; 8(2):71-82. PubMed ID: 6294157
[TBL] [Abstract][Full Text] [Related]
26. Magnesium regulation of the beta-receptor-adenylate cyclase complex. II. Sc3+ as a Mg2 antagonist.
Maguire ME
Mol Pharmacol; 1982 Sep; 22(2):274-80. PubMed ID: 6292689
[TBL] [Abstract][Full Text] [Related]
27. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
Barovsky K; Pedone C; Brooker G
Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
[TBL] [Abstract][Full Text] [Related]
28. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
MacEwan DJ; Kim GD; Milligan G
Mol Pharmacol; 1995 Aug; 48(2):316-25. PubMed ID: 7651365
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cyclic AMP accumulation in lymphoid cells.
Insel PA; Motulsky HJ; Mahan LC
Proc Soc Exp Biol Med; 1985 Sep; 179(4):472-8. PubMed ID: 2991940
[TBL] [Abstract][Full Text] [Related]
31. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
Nambi P; Whitman M; Stassen FL; Crooke ST
J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
[TBL] [Abstract][Full Text] [Related]
32. beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
Whitsett JA; Burdsall J; Workman L; Hollinger B; Neely J
J Natl Cancer Inst; 1983 Oct; 71(4):779-86. PubMed ID: 6312152
[TBL] [Abstract][Full Text] [Related]
33. Catecholamine-induced desensitization in turkey erythrocytes: cAMP mediated impairment of high affinity agonist binding without alteration in receptor number.
Stadel JM; De Lean A; Mullikin-Kilpatrick D; Sawyer DD; Lefkowitz RJ
J Cyclic Nucleotide Res; 1981; 7(1):37-47. PubMed ID: 6265513
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
Nash MS; Osborne NN
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
[TBL] [Abstract][Full Text] [Related]
35. Differential recovery of beta adrenoreceptor antagonist and agonist high affinity binding sites in the guinea-pig lung after irreversible blockade.
Nelson CA; Muther TF; Pitha J; Baker SP
J Pharmacol Exp Ther; 1986 Jun; 237(3):830-6. PubMed ID: 2872326
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of beta-adrenergic receptor internalization and down-regulation.
Mahan LC; Koachman AM; Insel PA
Proc Natl Acad Sci U S A; 1985 Jan; 82(1):129-33. PubMed ID: 2982140
[TBL] [Abstract][Full Text] [Related]
37. Agonist regulation of beta-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants.
Hadcock JR; Ros M; Malbon CC
J Biol Chem; 1989 Aug; 264(23):13956-61. PubMed ID: 2547776
[TBL] [Abstract][Full Text] [Related]
38. Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells.
Shear M; Insel PA; Melmon KL; Coffino P
J Biol Chem; 1976 Dec; 251(23):7572-6. PubMed ID: 187593
[TBL] [Abstract][Full Text] [Related]
39. Time-dependent decreases in binding affinity of agonists for beta-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization.
Insel PA; Mahan LC; Motulsky HJ; Stoolman LM; Koachman AM
J Biol Chem; 1983 Nov; 258(22):13597-605. PubMed ID: 6315705
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of downregulation of beta-adrenergic receptors: perspective on the role of beta-adrenergic receptors in congestive heart failure.
Frey MJ; Molinoff PB
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S13-8. PubMed ID: 2478805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
